Golden Finance reports that 180 Life Sciences Corp. (NASDAQ: ATNF) announced that it has sold approximately $156 million in principal amount of 2028 due priority guaranteed convertible bonds ("convertible bonds") to an institutional investor through a private placement on August 8. The company plans to use the net proceeds from the issuance of the convertible bonds to purchase more ETH. This issuance further expands the company's recently announced ETH fund management strategy. The company plans to regularly update investors on its ETH holdings in the short term to ensure maximum transparency.